-
公开(公告)号:US20210163919A1
公开(公告)日:2021-06-03
申请号:US16639305
申请日:2018-08-17
Applicant: ModernaTX, Inc.
Inventor: William Issa , Meredith Packer
Abstract: Aspects of the disclosure relate to liquid chromatography (e.g., HPLC) methods which enable high resolution separations of polynucleotides having hydrophobic portions (e.g., polyadenylated nucleic acids, such as mRNA) based upon the hydrophobic character of the molecules (e.g., polyA tail length). In some embodiments, the disclosure describes liquid chromatographic methods for separating a nucleic acid having a hydrophobic portion (e.g., a polyadenylated nucleic acid, such as an mRNA) from a complex mixture by a mobile phase system that comprises an ion pairing agent selected from Tris, inorganic cations (including e.g., Na, Li, K, ammonium, etc.), biological buffers (e.g., MOPS, HEPES, PIPES, etc.), and other charged or hydrophilic moieties, and lacks conventional ion pairing agents (e.g., Triethylammonium acetate, TEAA). Accordingly, in some embodiments methods described by the disclosure are useful for assessing the quality of pharmaceutical preparations comprising nucleic acids.
-
公开(公告)号:US20220339185A1
公开(公告)日:2022-10-27
申请号:US17850702
申请日:2022-06-27
Applicant: ModernaTX, Inc.
Inventor: Meredith Packer , Dipendra Gyawali , Serenus Hua , Gabor Butora , Gregory John Mercer
IPC: A61K31/7105 , A61K9/16
Abstract: Provided herein are compositions and methods of reducing adduct formation.
-
公开(公告)号:US20220273693A1
公开(公告)日:2022-09-01
申请号:US17508786
申请日:2021-10-22
Applicant: ModernaTX, Inc.
Inventor: Meredith Packer , Dipendra Gyawali , Serenus Hua , Gabor Butora , Gregory John Mercer
IPC: A61K31/7105 , A61K9/16
Abstract: Provided herein are compositions and methods of reducing adduct formation.
-
公开(公告)号:US20200239869A1
公开(公告)日:2020-07-30
申请号:US16639265
申请日:2018-08-17
Applicant: ModernaTX, Inc.
Inventor: William Issa , Meredith Packer
IPC: C12N15/10 , C12Q1/6876 , A61K48/00 , G01N30/34
Abstract: Aspects of the disclosure relate to liquid chromatography (e.g., HPLC) methods which enable high resolution separations of polynucleotides of various lengths, sequences, and/or base compositions in a highly tunable manner. In some embodiments, the disclosure describes liquid chromatographic methods for separating a nucleic acid (e.g., a polyadenylated nucleic acid, such as an mRNA) from a complex mixture by using multiple ion pairing agents in the same mobile phase system. Accordingly, in some embodiments methods described by the disclosure are useful for assessing the quality of pharmaceutical preparations comprising nucleic acids.
-
公开(公告)号:US20240016827A1
公开(公告)日:2024-01-18
申请号:US18205229
申请日:2023-06-02
Applicant: ModernaTX, Inc.
Inventor: Meredith Packer , Dipendra Gyawali , Serenus Hua , Gabor Butora , Gregory John Mercer
IPC: A61K31/7105 , A61K9/16
CPC classification number: A61K31/7105 , A61K9/1617 , A61K9/1641
Abstract: Provided herein are compositions and methods of reducing adduct formation.
-
公开(公告)号:US11866696B2
公开(公告)日:2024-01-09
申请号:US16639265
申请日:2018-08-17
Applicant: ModernaTX, Inc.
Inventor: William Issa , Meredith Packer
CPC classification number: C12N15/101 , A61K48/0091 , C12Q1/6876 , G01N30/34 , G01N2030/027 , G01N2030/8827
Abstract: Aspects of the disclosure relate to liquid chromatography (e.g., HPLC) methods which enable high resolution separations of polynucleotides of various lengths, sequences, and/or base compositions in a highly tunable manner. In some embodiments, the disclosure describes liquid chromatographic methods for separating a nucleic acid (e.g., a polyadenylated nucleic acid, such as an mRNA) from a complex mixture by using multiple ion pairing agents in the same mobile phase system. Accordingly, in some embodiments methods described by the disclosure are useful for assessing the quality of pharmaceutical preparations comprising nucleic acids.
-
公开(公告)号:US11524023B2
公开(公告)日:2022-12-13
申请号:US17508786
申请日:2021-10-22
Applicant: ModernaTX, Inc.
Inventor: Meredith Packer , Dipendra Gyawali , Serenus Hua , Gabor Butora , Gregory John Mercer
IPC: A61K31/7105 , A61K9/16
Abstract: Provided herein are compositions and methods of reducing adduct formation.
-
公开(公告)号:US20250092440A1
公开(公告)日:2025-03-20
申请号:US18294279
申请日:2022-08-01
Applicant: ModernaTX, Inc.
Inventor: Meredith Packer , Kevin Cognata
IPC: C12Q1/6811 , B01D15/32
Abstract: Aspects of the disclosure relate to liquid chromatography (e.g., HPLC) methods which enable identification of one or more target nucleic acids in a mixture (e.g., pharmaceutical composition). The disclosure is based, in part, on methods that allow for addition of pharmaceutical compositions (e.g., lipid-based pharmaceutical compositions) directly onto a chromatographic column without the need for first separating target nucleic acids out of the composition. Accordingly, in some embodiments, methods described by the disclosure are useful for assessing the quality of pharmaceutical preparations comprising nucleic acids.
-
公开(公告)号:US11912982B2
公开(公告)日:2024-02-27
申请号:US16639305
申请日:2018-08-17
Applicant: ModernaTX, Inc.
Inventor: William Issa , Meredith Packer
CPC classification number: C12N15/101 , G01N30/02 , G01N2030/8827 , G01N2496/00
Abstract: Aspects of the disclosure relate to liquid chromatography (e.g., HPLC) methods which enable high resolution separations of polynucleotides having hydrophobic portions (e.g., polyadenylated nucleic acids, such as mRNA) based upon the hydrophobic character of the molecules (e.g., polyA tail length). In some embodiments, the disclosure describes liquid chromatographic methods for separating a nucleic acid having a hydrophobic portion (e.g., a polyadenylated nucleic acid, such as an mRNA) from a complex mixture by a mobile phase system that comprises an ion pairing agent selected from Tris, inorganic cations (including e.g., Na, Li, K, ammonium, etc.), biological buffers (e.g., MOPS, HEPES, PIPES, etc.), and other charged or hydrophilic moieties, and lacks conventional ion pairing agents (e.g., Triethylammonium acetate, TEAA). Accordingly, in some embodiments methods described by the disclosure are useful for assessing the quality of pharmaceutical preparations comprising nucleic acids.
-
公开(公告)号:US11622972B2
公开(公告)日:2023-04-11
申请号:US17850702
申请日:2022-06-27
Applicant: ModernaTX, Inc.
Inventor: Meredith Packer , Dipendra Gyawali , Serenus Hua , Gabor Butora , Gregory John Mercer
IPC: A61K31/7105 , A61K9/16
Abstract: Provided herein are compositions and methods of reducing adduct formation.
-
-
-
-
-
-
-
-
-